Elekta AB (OTCMKTS:EKTAY - Get Free Report)'s stock price traded down 1% during mid-day trading on Thursday . The stock traded as low as $4.91 and last traded at $4.91. 2,585 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 7,817 shares. The stock had previously closed at $4.96.
Wall Street Analysts Forecast Growth
Separately, Danske lowered Elekta to a "hold" rating in a report on Tuesday, June 3rd.
Check Out Our Latest Analysis on Elekta
Elekta Stock Performance
The stock has a market cap of $1.88 billion, a price-to-earnings ratio of 98.22 and a beta of 1.22. The company's 50 day simple moving average is $5.09 and its 200 day simple moving average is $5.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.86 and a current ratio of 1.09.
Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.13 by ($0.02). Elekta had a net margin of 1.15% and a return on equity of 11.55%. The company had revenue of $503.22 million during the quarter, compared to the consensus estimate of $507.19 million. On average, equities research analysts anticipate that Elekta AB will post 0.36 earnings per share for the current year.
About Elekta
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Elekta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta wasn't on the list.
While Elekta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
